![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Bentham Science Publishers
E-ISSN: 1873-5592|7|7|887-891
ISSN: 1389-4501
Source: Current Drug Targets, Vol.7, Iss.7, 2006-07, pp. : 887-891
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Antiviral therapy `economically reasonable' for influenza
Inpharma, Vol. 1, Iss. 1362, 2002-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Non-ribosomal peptide antibiotics
Expert Opinion on Therapeutic Patents, Vol. 10, Iss. 10, 2000-10 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
ICD therapy economically attractive in patients with stable HF
Inpharma, Vol. 1, Iss. 1559, 2006-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
ICD therapy economically attractive in patients with stable HF
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 513, 2006-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Inappropriate therapy for MRSA costly, potentially deadly, problem
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 561, 2008-01 ,pp. :